Imugene (ASX: IMU) Share Price

IMU

$0.091–+0.00%

$37.8MRank #1099 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$37.8M

Volume

2.3M

P/E Ratio

-0.7

EPS

-$0.1296

Dividend Yield

0.00%

52-Week High

$0.544

52-Week Low

$0.09

Beta

2.151

Imugene (ASX: IMU) is an Australian-listed company in the Healthcare sector with a market capitalisation of $37.8M and the 1099th-largest security on the ASX by market capitalisation. The IMU share price is $0.091, up 0.00% today and down 81.96% over the past 12 months. Shares have traded between $0.09 and $0.544 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Imugene reported revenue of $0 and a net loss of $37.8M.

Charts

$0.09

24H Range

$0.091

$0.094

52-Week Range

$0.09

$0.544

About Imugene Limited

Imugene Limited is an Australian clinical-stage immuno-oncology firm focused on creating innovative immunotherapies. Its core mission is to activate the immune systems of cancer patients, enabling them to effectively fight and eradicate tumors. A primary asset in their development pipeline is HER-Vaxx, a vaccine tailored for HER2-positive cancers. This therapy works by stimulating the body to generate a diverse antibody response against HER2/neu receptors, specifically targeting gastric and breast cancers. HER-Vaxx is currently progressing through Phase 1b/2 clinical studies for gastric cancer indications. Beyond HER-Vaxx, the company is also developing PD1-Vaxx, another cancer vaccine designed to prompt the body to produce antibodies that block PD-1 signaling. Additionally, they are advancing CF33, which combines genomic material from various vaccinia virus strains to engineer a highly potent virus. Imugene has established key partnerships, including a research collaboration with Celularity Inc. to integrate Imugene's CD19 oncolytic virus technology with Celularity's CD19-targeting allogeneic chimeric antigen receptor T-cell therapy, CyCART-19, for solid tumor treatment. The company also maintains a strategic collaboration with Eureka Therapeutics, Inc. Founded in 1986, Imugene Limited is headquartered in Sydney, Australia.

IPO Date

31 Dec 1998

CEO

Leslie Chong

Website

imugene.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-37.8M
Total Assets	$67.7M
Total Debt	$5.0M
Free Cash Flow	$-26.0M
Return on Equity	-90.34%
Profit Margin	—
Operating Margin	—

IMU Frequently Asked Questions

What is the Imugene (ASX: IMU) share price?

The IMU share price is $0.091, up 0.00% for the day, based on the latest available ASX market data.

What is Imugene's market capitalisation?

Imugene has a market capitalisation of $37.8M, making it the 1099th-largest security listed on the ASX.

Does Imugene pay a dividend?

IMU does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Imugene profitable?

In its most recent reported period (ending 31 Dec 2025), IMU reported revenue of $0 and a net loss of $37.8M.

How many IMU shares are on issue?

Imugene has approximately 415,835,000 shares on issue, based on its market capitalisation of $37.8M and current share price.

What sector is Imugene in?

Imugene is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Imugene list on the ASX?

Imugene listed on the Australian Securities Exchange on 31 Dec 1998.

Latest News

Imugene (ASX:IMU) Shares Rally as FDA Grants Special Status to Lead Cancer Therapy

Kalkine9 June 2026

Imugene (ASX:IMU) Shares Rally as FDA Grants Special Status to Lead Cancer Therapy Kalkine

FDA grants Fast Track to Imugene blood cancer therapy

grafa.com9 June 2026

FDA grants Fast Track to Imugene blood cancer therapy grafa.com

Imugene CEO Leslie Chong discusses FDA Fast Track Designation

Proactive financial news9 June 2026

Imugene CEO Leslie Chong discusses FDA Fast Track Designation Proactive financial news

OPTION EXPIRING 30-MAR-2026 (ASX:IMUO)

intelligentinvestor.com.au30 Mar 2026

OPTION EXPIRING 30-MAR-2026 (ASX:IMUO) intelligentinvestor.com.au

FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI

Proactive financial news12 June 2026

FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI Proactive financial news

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
SPLStarpharma Holdings Limited	$286.2M	$0.68	27.58	0.00%	▲+1.49%
RCERecce Pharmaceuticals Ltd	$144.6M	$0.50	-2.84	0.00%	▲+2.04%
ACWActinogen Medical Limited	$122.0M	$0.034	-4.28	0.00%	–+0.00%
ATHAlterity Therapeutics Limited	$107.7M	$0.495	-2.12	0.00%	▲+11.24%
ILAIsland Pharmaceuticals Limited	$95.0M	$0.38	-5.66	0.00%	▲+7.04%
ALAArovella Therapeutics Limited	$81.0M	$0.067	-14.80	0.00%	▲+1.52%
BIOBiome Australia Limited	$62.7M	$0.275	19.71	0.00%	–+0.00%
RADRadiopharm Theranostics Limited	$47.3M	$0.02	-0.82	0.00%	▲+5.26%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.091	$0.094	$0.091	$0.092	2.2M	▲+1.10%
11 June 2026	$0.093	$0.093	$0.09	$0.091	3.5M	▼-3.19%
10 June 2026	$0.096	$0.097	$0.092	$0.094	2.9M	–+0.00%
9 June 2026	$0.092	$0.105	$0.09	$0.094	8.4M	▲+2.17%
8 June 2026	$0.094	$0.095	$0.092	$0.092	2.4M	▼-1.08%
5 June 2026	$0.094	$0.095	$0.092	$0.093	2.3M	▼-1.06%
4 June 2026	$0.097	$0.098	$0.092	$0.094	4.3M	▼-3.09%
3 June 2026	$0.11	$0.11	$0.096	$0.097	6.9M	▼-9.35%
2 June 2026	$0.11	$0.11	$0.105	$0.107	671K	▲+1.90%
1 June 2026	$0.11	$0.112	$0.105	$0.105	2.3M	▼-4.55%
29 May 2026	$0.11	$0.115	$0.105	$0.11	1.6M	–+0.00%
28 May 2026	$0.115	$0.117	$0.11	$0.11	1.1M	▼-4.35%
27 May 2026	$0.13	$0.13	$0.11	$0.115	2.8M	▼-4.17%
26 May 2026	$0.11	$0.13	$0.11	$0.12	2.7M	▲+7.14%
25 May 2026	$0.135	$0.135	$0.11	$0.112	2.6M	▼-11.81%
22 May 2026	$0.11	$0.13	$0.105	$0.127	6.8M	▲+27.00%
21 May 2026	$0.095	$0.105	$0.095	$0.10	1.8M	▲+7.53%
20 May 2026	$0.094	$0.096	$0.092	$0.093	1.4M	–+0.00%
19 May 2026	$0.091	$0.094	$0.091	$0.093	1.1M	▲+1.09%
18 May 2026	$0.095	$0.095	$0.09	$0.092	3M	▼-5.15%
15 May 2026	$0.096	$0.10	$0.094	$0.097	3.9M	▲+2.11%
14 May 2026	$0.105	$0.105	$0.093	$0.095	3M	▼-6.86%
13 May 2026	$0.105	$0.105	$0.10	$0.102	830K	▼-2.86%
12 May 2026	$0.11	$0.11	$0.105	$0.105	1.8M	▼-4.55%
11 May 2026	$0.105	$0.11	$0.105	$0.11	2.1M	–+0.00%
8 May 2026	$0.115	$0.115	$0.107	$0.11	1.3M	▼-1.79%
7 May 2026	$0.11	$0.112	$0.105	$0.112	1.3M	▲+4.67%
6 May 2026	$0.115	$0.115	$0.105	$0.107	555K	▼-2.73%
5 May 2026	$0.105	$0.115	$0.105	$0.11	904K	▲+2.80%
4 May 2026	$0.11	$0.112	$0.105	$0.107	526K	▼-2.73%

About Imugene Limited

IPO Date

31 Dec 1998

CEO

Leslie Chong

Website

imugene.com

IMU Frequently Asked Questions

What is the Imugene (ASX: IMU) share price?

The IMU share price is $0.091, up 0.00% for the day, based on the latest available ASX market data.

What is Imugene's market capitalisation?

Imugene has a market capitalisation of $37.8M, making it the 1099th-largest security listed on the ASX.

Does Imugene pay a dividend?

IMU does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Imugene profitable?

In its most recent reported period (ending 31 Dec 2025), IMU reported revenue of $0 and a net loss of $37.8M.

How many IMU shares are on issue?

Imugene has approximately 415,835,000 shares on issue, based on its market capitalisation of $37.8M and current share price.

What sector is Imugene in?

Imugene is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Imugene list on the ASX?

Imugene listed on the Australian Securities Exchange on 31 Dec 1998.

Company

Market Cap

Price

P/E

Div Yield

1D Change

SPLStarpharma Holdings Limited

$286.2M

$0.68

27.58

0.00%

▲+1.49%

RCERecce Pharmaceuticals Ltd

$144.6M

$0.50

-2.84

0.00%

▲+2.04%

ACWActinogen Medical Limited

$122.0M

$0.034

-4.28

0.00%

–+0.00%

ATHAlterity Therapeutics Limited

$107.7M

$0.495

-2.12

0.00%

▲+11.24%

ILAIsland Pharmaceuticals Limited

$95.0M

$0.38

-5.66

0.00%

▲+7.04%

ALAArovella Therapeutics Limited

$81.0M

$0.067

-14.80

0.00%

▲+1.52%

BIOBiome Australia Limited

$62.7M

$0.275

19.71

0.00%

–+0.00%

RADRadiopharm Theranostics Limited

$47.3M

$0.02

-0.82

0.00%

▲+5.26%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.091	$0.094	$0.091	$0.092	2.2M	▲+1.10%
11 June 2026	$0.093	$0.093	$0.09	$0.091	3.5M	▼-3.19%
10 June 2026	$0.096	$0.097	$0.092	$0.094	2.9M	–+0.00%
9 June 2026	$0.092	$0.105	$0.09	$0.094	8.4M	▲+2.17%
8 June 2026	$0.094	$0.095	$0.092	$0.092	2.4M	▼-1.08%
5 June 2026	$0.094	$0.095	$0.092	$0.093	2.3M	▼-1.06%
4 June 2026	$0.097	$0.098	$0.092	$0.094	4.3M	▼-3.09%
3 June 2026	$0.11	$0.11	$0.096	$0.097	6.9M	▼-9.35%
2 June 2026	$0.11	$0.11	$0.105	$0.107	671K	▲+1.90%
1 June 2026	$0.11	$0.112	$0.105	$0.105	2.3M	▼-4.55%
29 May 2026	$0.11	$0.115	$0.105	$0.11	1.6M	–+0.00%
28 May 2026	$0.115	$0.117	$0.11	$0.11	1.1M	▼-4.35%
27 May 2026	$0.13	$0.13	$0.11	$0.115	2.8M	▼-4.17%
26 May 2026	$0.11	$0.13	$0.11	$0.12	2.7M	▲+7.14%
25 May 2026	$0.135	$0.135	$0.11	$0.112	2.6M	▼-11.81%
22 May 2026	$0.11	$0.13	$0.105	$0.127	6.8M	▲+27.00%
21 May 2026	$0.095	$0.105	$0.095	$0.10	1.8M	▲+7.53%
20 May 2026	$0.094	$0.096	$0.092	$0.093	1.4M	–+0.00%
19 May 2026	$0.091	$0.094	$0.091	$0.093	1.1M	▲+1.09%
18 May 2026	$0.095	$0.095	$0.09	$0.092	3M	▼-5.15%
15 May 2026	$0.096	$0.10	$0.094	$0.097	3.9M	▲+2.11%
14 May 2026	$0.105	$0.105	$0.093	$0.095	3M	▼-6.86%
13 May 2026	$0.105	$0.105	$0.10	$0.102	830K	▼-2.86%
12 May 2026	$0.11	$0.11	$0.105	$0.105	1.8M	▼-4.55%
11 May 2026	$0.105	$0.11	$0.105	$0.11	2.1M	–+0.00%
8 May 2026	$0.115	$0.115	$0.107	$0.11	1.3M	▼-1.79%
7 May 2026	$0.11	$0.112	$0.105	$0.112	1.3M	▲+4.67%
6 May 2026	$0.115	$0.115	$0.105	$0.107	555K	▼-2.73%
5 May 2026	$0.105	$0.115	$0.105	$0.11	904K	▲+2.80%
4 May 2026	$0.11	$0.112	$0.105	$0.107	526K	▼-2.73%